Literature DB >> 7061843

Inhibition of lymphocyte protein synthesis by fibrinogen-derived peptides.

E F Plow, D Freaney, T S Edgington.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7061843

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  5 in total

1.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 2.  Immunomodulating peptides.

Authors:  G H Werner; F Floc'h; D Migliore-Samour; P Jollès
Journal:  Experientia       Date:  1986-05-15

Review 3.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

4.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

Authors:  M Clauss; M Gerlach; H Gerlach; J Brett; F Wang; P C Familletti; Y C Pan; J V Olander; D T Connolly; D Stern
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

5.  In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies.

Authors:  M S Abaza; F A Shaban; R K Narayan; M Z Atassi
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.